상단으로
Choose your location
Select your country or region to view content specific to your country.
Choose your country
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
2013 Symposium for the Society of Clinical Microbiology
Jan 30, 2013
The Symposium for the Society of Clinical Microbiology was held in the Yeouido St. Mary's Hospital on the 25th of January. With the theme, “New Horizon in Clinical Microbiology”, this conference dealt with the recent advances in Microbiology.
At the event, Seegene also had the chance to fully introduce its pathogen diagnostic product for infectious diseases, which was also approved by the Korea Food & Drug Administration (KFDA) as an in vitro diagnostic reagent. With the KFDA approval of Seegene’s main products (diagnostic tests for respiratory viruses, pneumonia pathogens, Human Papilloma virus Infection viruses, sexually transmitted infection pathogens, tuberculosis germs as well as tuberculosis drug resistances), Seegene received much attention from scholars.
Meanwhile, acknowledging the importance of in vitro diagnostic reagents in the analysis of diagnostic tests, the KDFA revised the Medical Appliances Act of July 2011 and established the in vitro diagnostic reagents as a part of Medical Device. KDFA plans to strictly oversee the performance and safety of the reagent.
Seegene also successfully participated in the 2013 Arab Health held in Dubai this past January 28 to 31.